© Copyright Acquisition International 2026 - All Rights Reserved.

Article Image - Bio-Techne Corporation Agrees to Acquire Zephyrus Biosciences, Inc.
Posted 21st March 2016

Bio-Techne Corporation Agrees to Acquire Zephyrus Biosciences, Inc.

Bio-Techne Corporation (NASDAQ: TECH) announced today that it has completed the acquisition of Zephyrus Biosciences.

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Bio-Techne Corporation Agrees to Acquire Zephyrus Biosciences, Inc.
Image

Bio-Techne Corporation (NASDAQ: TECH) announced today that it has completed the acquisition of Zephyrus Biosciences.  Zephyrus Biosciences will be integrated into the Protein Platforms Division of Bio-Techne.

Zephyrus Biosciences provides research tools to enable protein analysis at the single cell level. Addressing the burgeoning single cell analysis market, Zephyrus’s first product, the Z1™ System, enables western blotting on individual cells for the first time. Researchers will utilize Zephyrus’s products to gain new insights into the biology of cancer, stem cells, neurology, and human disease and development. Zephyrus spun out from Dr. Amy Herr’s laboratory at U.C. Berkeley in 2013 and has affiliations with QB3, StartX, CLSI/BayBio, and Berkeley SkyDeck. 

Charles R. Kummeth, President and Chief Executive Officer of Bio-Techne, said:

“The acquisition of Zephyrus demonstrates our continued interest in western blotting, a vital technique in protein identification and characterization. This new technology brings this technique to the single cell level, allowing us to address both homogenous sample populations with our Simple Western™ platforms and now heterogeneous populations at the single cell level with Zephyrus and the Z1 System. We are very excited to bring the Zephyrus products and team onboard.”

Zephyrus co-founder and Chief Executive Officer Kelly Gardner, Ph.D. added:

“We are excited to join Bio-Techne and bring our system into the ProteinSimple family of products. This deal provides an excellent path forward for commercialization of the single cell Western Blot (scWestern Blot) technology.  The market reach of Bio-Techne will enable Zephyrus to rapidly reach the broad market of researchers who need to study proteins at the single cell level.”

Dr. Gardner and other members of the Zephyrus team will remain in place following the closing.

Categories: M&A


You Might Also Like
Read Full PostRead - Eye Icon
Hogan Lovells Advise Mapfre’s Acquisition of Direct Line
Finance
30/07/2015Hogan Lovells Advise Mapfre’s Acquisition of Direct Line

Hogan Lovells Advise Mapfre's Acquisition of Direct Line

Read Full PostRead - Eye Icon
Hard Landings and High Stakes: Legal Considerations After a Traumatic Aircraft Touchdown
Legal
26/01/2026Hard Landings and High Stakes: Legal Considerations After a Traumatic Aircraft Touchdown

Commercial aviation is designed around precision, safety, and rigorous operational standards. However, when an aircraft experiences a hard or unstable landing, the consequences can extend far beyond temporary discomfort. These incidents can result in serious p

Read Full PostRead - Eye Icon
The Race to Net Zero: How Businesses Can Cut Energy Costs and Carbon Emissions Simultaneously
Corporate Social Responsibility
15/04/2025The Race to Net Zero: How Businesses Can Cut Energy Costs and Carbon Emissions Simultaneously

Andrew King is the founder of SGT, a Buckinghamshire-based firm helping businesses across the UK find commercial energy tariffs that meet their needs while keeping costs low. Andrew explores how businesses can cut energy costs while also cutting down their car

Read IssueRead - Eye Icon
Issue 9 2024
Issues
05/09/2024Issue 9 2024

As we approach the end of 2024’s third quarter, we take another moment to appreciate what has gone in the months before. Recently, we have crowned a range of tenacious and committed individuals and businesses and, here, we wish to showcase and celebrate thei

Read Full PostRead - Eye Icon
Defense Experts in the Areas of DNA Profiling
Innovation
26/11/2018Defense Experts in the Areas of DNA Profiling

Dean A. Stetler and Associates, Inc provides their expertise and knowledge of biological science, particularly of DNA profiling, to criminal defenses. Recently, we profiled both Dean Stetler and Dean A. Stetler and Associates, Inc to discover more about the aw

Read Full PostRead - Eye Icon
6 Ways to Reduce Accounting Errors In SMBs
Finance
03/02/20226 Ways to Reduce Accounting Errors In SMBs

For any business in general, accounting is a crucial part of operations. But for small- and medium-size businesses (SMBs) in particular, it’s an aspect that should be handled with utmost care. Given the size of the organization, even the slightest mistake co

Read Full PostRead - Eye Icon
North American M&A Volume Increased in November
Finance
15/12/2015North American M&A Volume Increased in November

There were 1,556 mergers and acquisitions (M&A) deals worth a combined USD 121,727 million targeting North American companies announced in November.

Read Full PostRead - Eye Icon
ARQIS advises Oerlikon on the acquisition of AC-Automation
Legal
25/04/2018ARQIS advises Oerlikon on the acquisition of AC-Automation

ARQIS has advised Oerlikon on the acquisition of German-based AC-Automation GmbH & Co. KG.

Read Full PostRead - Eye Icon
Trowers & Hamlin Advise on Cygnet Healthcare Acquisition of Alpha Hospitals
Legal
27/08/2015Trowers & Hamlin Advise on Cygnet Healthcare Acquisition of Alpha Hospitals

Trowers & Hamlin Advise on Cygnet Healthcare Acquisition of Alpha Hospitals



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow